Insurance

Japan Post Holdings trims its stake in Aflac, yet the insurer keeps its strategic focus on accident‑and‑health products and AI‑powered underwriting, positioning it to navigate evolving risks while maintaining robust financial performance.

New Mediobanca upgrade to “outperform” for Sampo lifts target price to €5.80, citing stronger premium growth, but regulatory costs, competition, and conflict‑of‑interest risks temper optimism.

Arthur J. Gallagher & Co. prepares for its next investor meeting, spotlighting Q1 growth, robust capital ratios, and strategic moves in digital, ESG, and global expansion.

QBE’s strategic debt redemption and €500 m subordinated note issuance boosts solvency, cuts interest risk, and fuels growth in cyber‑ and climate‑risk insurance, giving it a sharper competitive edge in a consolidating market.

Neutral outlook for Gjensidige Forsikring: Mediobanca’s new target of 290 NOK reflects solid underwriting, tech‑driven claims and climate‑risk strategies, signalling steady growth amid Norwegian market volatility.

China’s June 2026 equity market shows insurance decline while tech and biopharma rise—explore sector shifts, volume spikes, and investor sentiment.

Sun Life’s Medzown partnership promises AI‑driven clinical trial access but lacks clear metrics, raises conflict‑of‑interest concerns, and leaves data privacy and cost‑savings unproven.

Hannover Rück shares rise 1.8% as a 39% dividend jump fuels optimism, yet analysts warn of risk‑adjusted returns amid market volatility and catastrophe exposure.

Explore why Münchener Rück’s stock slipped 1.5 %, uncovering hidden risks, reinsurance spikes and premium stagnation that could reshape its future.

Ping An Insurance Group Co‑A’s recent stock moves show modest gains driven by a few institutional inflows and inflated valuation ratios, not solid earnings growth.